The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robyn T Domsic, MD
University of Pittsburgh
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Delricht Research Center
New Orleans, Louisiana, United States
Lesley Saketkoo, MD MPHRecruiting - University of Michigan
Ann Arbor, Michigan, United States
Dinesh Khanna, MDRecruiting - University of Pittsburgh and Upmc Scleroderma Center
Pittsburgh, Pennsylvania, United States
Robyn T Domsic, MDRecruiting - Vanderbilt University Medical Center
Nashville, Tennessee, United States
Tracy Frech, MD MSRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jan 2025
- Primary completion
- 1 Mar 2028
- Completion
- 30 Sept 2028
- Last update posted
- 8 Jan 2026
- Registered enrollment
- 160
- Registry id
- NCT06675344
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.